Substitution arrangement for gliclazide

Nicholas O’Donoghue 29/02/2024

Ongoing shortages of gliclazide 30mg products prompt department to issue substitution instrument Pharmacists can now dispense specific 60mg gliclazide oral tablets as alternatives to brands of 30mg formulations. The department of health and aged care issued the Therapeutic Goods (Serious Scarcity and Substitutable Medicines) (Gliclazide) Instrument 2024 earlier this week (27 February), enabling pharmacists to

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Substitution arrangement for gliclazide

Previous Annual Covid boosters confirmed

Next ‘That undercurrent of bullying and harassment’

MENU

ajp.com.au

Previous Annual Covid boosters confirmed

Next ‘That undercurrent of bullying and harassment’

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.